Cargando…
596 Application of Intravenous Immunoglobulin for Treatment of Chronic Autoimmune Urticaria
BACKGROUND: To develop a patogenetically justified method for treatment of the autoimmune form of chronic urticaria. METHODS: 14 patients with autoimmune urticaria (18–60 y-o., time since disease onset ranging from 6 weeks to 5 years), having positive autoserum test results (7 mm or more in 11 patie...
Autor principal: | Alyoshkin, Vladimir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization Journal
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512593/ http://dx.doi.org/10.1097/01.WOX.0000411711.09881.b5 |
Ejemplares similares
-
581 Chronic Urticaria and Infections
por: Aguilar, Nadia, et al.
Publicado: (2012) -
281 Use of Monoclonal Antibody Omalizumab in the Treatment of Urticaria Chronic
por: Correa, Jorge Vargas
Publicado: (2012) -
541 Intravenous Immunoglobulin in Leukocyte Adhesion Deficiency
por: Oropeza, Said Arablin, et al.
Publicado: (2012) -
269 Refractory Chronic Urticaria Treated with Omalizumab
por: Saenz, Martinez, et al.
Publicado: (2012) -
593 Chronic Urticaria as First Sign of Sarcoidosis
por: Pérez-Bustamante, María Socorro, et al.
Publicado: (2012)